Skip to main content
Aplab Ltd. logo

Aplab Ltd. — Investor Relations & Filings

Ticker · 890217 ISIN · IN9273A01047 LEI · 3358005DVRNWJLJH2Y24 BSE.NS Manufacturing
Filings indexed 351 across all filing types
Latest filing 2023-08-11 Regulatory Filings
Country IN India
Listing BSE.NS 890217

About Aplab Ltd.

https://www.aplab.com

Aplab Ltd. specializes in the design, manufacture, and marketing of professional electronic equipment. The product portfolio includes test and measurement instruments, power conversion and control systems, uninterruptible power supplies (UPS), and solar power solutions. The company also provides specialized hardware for banking and retail automation, including automated teller machines and self-service kiosks. Serving sectors such as defense, telecommunications, education, and industrial manufacturing, the organization focuses on research and development to deliver high-precision laboratory instruments and robust power electronics. Its solutions encompass smart card-based systems and specialized power supplies for critical infrastructure, emphasizing technical reliability and engineering excellence.

Recent filings

Filing Released Lang Actions
Approval of Un-audited Financial Results for the first quarter ended 30th June, 2023 and other matters.
Regulatory Filings
2023-08-11 English
Outcome of Board Meeting dated 11th August, 2023 for financial results for the quarter ended 30th June, 2023 and other matters.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) reporting the outcome of a board meeting held on August 11, 2023. It mentions approval of un-audited financial results for the first quarter ended June 30, 2023, and a limited review report by statutory auditors on those results. It also announces the appointment of an additional director. The document is short (1417 characters) and serves as an announcement of the board meeting outcome and financial results approval, not the full financial report itself. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not contain the full interim report or detailed financial statements.
2023-08-11 English
APLAB LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve the Un-audited Financial Results for ....
Regulatory Filings Classification · 95% confidence The document is a letter notifying the stock exchange (BSE Limited) about the convening of a Board Meeting to consider and approve the unaudited financial results for the first quarter ended June 30, 2023. It is an announcement of an upcoming event related to financial results, not the financial results report itself. The document is short (1267 characters) and serves as a notice rather than containing substantive financial data or analysis. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-08-01 English
Certificate under Reg.74(5) of SEBI (DP) Regulations for the quarter ended 30th June, 2023.
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended June 30, 2023. It is a confirmation certificate issued by the Registrar and Share Transfer Agents, not a financial report or detailed filing. The document is short (2580 characters) and serves as a compliance confirmation rather than a report or announcement of financial results. It is primarily an attestation letter confirming regulatory compliance, which fits the criteria for Regulatory Filings (RNS) rather than a financial report or other specific filing types.
2023-07-07 English
Closure of Trading Window for dealing in shares of the company for Promoters, Directors, KMPs, Designated Employees, Audit/Law Firms etc from 5th July, 2023.
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about the closure of the trading window for insiders ahead of the announcement of the company's unaudited financial results for the first quarter ended June 30, 2023. It references regulatory compliance with SEBI insider trading regulations and mentions the upcoming board meeting date will be intimated later. The document does not contain any financial data or results itself, nor does it provide a report or detailed financial analysis. It is an announcement related to trading restrictions prior to financial results disclosure. Given the short length (1422 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2023-07-04 English
Statement of Impact of Audit Qualifications for Audit Report with Modified Opinion for the year ended 31st March, 2023
Regulatory Filings
2023-06-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.